Hormonal contraception and migraine: Clinical considerations

Stephanie S. Faubion, Petra M. Casey, Lynne T. Shuster

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Migraine is highly prevalent in women, particularly in the reproductive years when contraception may be needed. Preventive strategies are known to be underutilized for migraine. Women of reproductive age may not only benefit from the use of hormonal contraceptives for contraception, but also for the purpose of reducing the burden of menstrual-related migraine. Although migraine is associated with an increased risk of stroke, the use of low-dose hormonal contraceptives in otherwise healthy women does not appear to confer additional risk.

Original languageEnglish (US)
Pages (from-to)461-466
Number of pages6
JournalCurrent pain and headache reports
Issue number5
StatePublished - Oct 2012


  • Combined hormonal contraceptive
  • Estrogen
  • Menstrual migraine
  • Migraine
  • Oral contraceptive
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Hormonal contraception and migraine: Clinical considerations'. Together they form a unique fingerprint.

Cite this